Back to Search
Start Over
Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)
- Source :
- Journal of Clinical Oncology. 33:e15594-e15594
- Publication Year :
- 2015
- Publisher :
- American Society of Clinical Oncology (ASCO), 2015.
-
Abstract
- e15594 Background: Data about complete remission in patient with metastatic mRCC in TKIs era are extremely limited. We performed a multicenter, retrospective analysis of patients who obtained CR du...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Pathology
business.industry
Complete remission
Hematology
urologic and male genital diseases
medicine.disease
humanities
respiratory tract diseases
body regions
Renal cell carcinoma
Internal medicine
Cancer research
medicine
Retrospective analysis
In patient
business
Tyrosine kinase
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....21dfce58c9c02d93c6aaf345e4bddbfa